1. Stem Cell Res. 2019 Oct;40:101578. doi: 10.1016/j.scr.2019.101578. Epub 2019
Sep  12.

Generation of an integration-free iPSC line, ICCSICi005-A, derived from a 
Parkinson's disease patient carrying the L444P mutation in the GBA1 gene.

Rodríguez-Traver E(1), Rodríguez C(2), Díaz-Guerra E(1), Arenas F(3), 
Araúzo-Bravo M(4), Orera M(2), Kulisevsky J(3), Moratalla R(1), Vicario C(5).

Author information:
(1)Instituto Cajal-Consejo Superior de Investigaciones Científicas (CSIC), 
Madrid, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades 
Neurodegenerativas (CIBERNED), Madrid, Spain.
(2)Servicio de Bioquímica Clínica, Hospital General Universitario Gregorio 
Marañón, Madrid, Spain.
(3)Centro de Investigación Biomédica en Red sobre Enfermedades 
Neurodegenerativas (CIBERNED), Madrid, Spain; Movement Disorders Unit, Neurology 
Dept., Hospital Sant Pau, Barcelona, Spain.
(4)Biodonostia Health Research Institute, San Sebastián, Spain.
(5)Instituto Cajal-Consejo Superior de Investigaciones Científicas (CSIC), 
Madrid, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades 
Neurodegenerativas (CIBERNED), Madrid, Spain. Electronic address: 
cvicario@cajal.csic.es.

The L444P mutation in the GBA1 gene which encodes β-glucocerebrosidase-1, is a 
major risk factor for developing Parkinson's disease (PD) and dementia with Lewy 
bodies (DLB). We report the generation and characterization of an induced 
pluripotent stem cell (iPSC) line derived from a female PD patient carrying the 
L444P/wt mutation. The iPSC line presented a normal morphology, expressed 
endogenous pluripotency markers, could be differentiated into endodermal, 
mesodermal and ectodermal cells, was free from Sendai vectors and reprogramming 
factors, had a normal karyotype and maintained the original GBA1 genotype. Thus, 
this iPSC line can serve to establish cellular models of PD.

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

DOI: 10.1016/j.scr.2019.101578
PMID: 31539859 [Indexed for MEDLINE]